Statements (14)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Clinical_Trials
|
| gptkbp:condition |
psoriasis
|
| https://www.w3.org/2000/01/rdf-schema#label |
UNCOVER-2
|
| gptkbp:is_tested_for |
Phase 3
|
| gptkbp:location |
multiple countries
|
| gptkbp:prevention |
gptkb:risankizumab
|
| gptkbp:result |
efficacy and safety of risankizumab
|
| gptkbp:sponsor |
gptkb:Abb_Vie
|
| gptkbp:start_date |
2017-01-01
|
| gptkbp:status |
completed
|
| gptkbp:year |
2020-12-31
|
| gptkbp:bfsParent |
gptkb:ixekizumab
gptkb:Ixekizumab |
| gptkbp:bfsLayer |
6
|